Skip to content

Study · Not a test of the peptide alone · 2026

1 result

Enhanced Recovery and Postoperative Analgesia After Laparoscopic Myomectomy: A Randomized Controlled Trial Comparing Total Intravenous Anesthesia, Transversus Abdominis Plane Block with Rectus Sheath Block, and Quadratus Lumborum Block.

Zeng C, Ling G, Huang C, Pan T, Tang Y, Kong F, Dai L, Xiao W, Liang Y, Gong Z

Drug design, development and therapy22 Jun 2026

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01HumanNot a test of Oxytocin aloneRandomized controlled trialEfficacy outcome

    In patients having laparoscopic myomectomy, general anesthesia with quadratus lumborum block gave lower scores for oxytocin-induced contraction pain than the other two anesthesia methods.

    In plain wordsIn patients having laparoscopic myomectomy, the quadratus lumborum block gave less pain from oxytocin-induced uterine contractions than the two other anesthesia methods.

    Peptide
    Oxytocin
    Outcome
    DecreaseOxytocin-induced uterine contraction pain VAS at 24 hours
    Study

    n = 120

    Comparator
    Groups A (TIVA) and B (TAPB+RSB)
    Analysis
    Primary
    Outcome group
    Pain · Reproductive and sexual health

    Source sentences

    Summary
    Group C exhibited significantly lower oxytocin-induced contraction VAS scores than Groups B and A, with Group B also lower than A (all P<0.05).
    2 context sentences
    Summary · context
    The primary outcome was the visual analog scale (VAS) score for oxytocin-induced uterine contraction pain at 24 hours postoperatively (T16).
    Summary · context
    This was a prospective, single-center, randomized controlled trial involving 120 patients (1:1:1 randomization).

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.